Triptans May Not Raise Risk of Fetal Defects
PHILADELPHIA — Sumatriptan and naratriptan do not appear to significantly raise the risk of major congenital malformations in fetuses that are exposed to the drugs in utero, according to the latest analysis of an international pregnancy registry.
source : www.clinicalpsychiatrynews.com
How DUMB are YOU?!
Do your friends think you are stupid? Take the challenge and prove them wrong!
Get 5 Books for 99 cents!
The most popular books at the most popular prices!
Home Income Profit System
You can make money working from the comfort of your own home!
CreditReport.com
Get your credit report and score in just seconds!
Beat your friends on IQ Challenge!
Take the 10-Minute IQ Challenge today. Prove to your friends that you aren't stupid after all!
Do your friends think you are stupid? Take the challenge and prove them wrong!
Get 5 Books for 99 cents!
The most popular books at the most popular prices!
Home Income Profit System
You can make money working from the comfort of your own home!
CreditReport.com
Get your credit report and score in just seconds!
Beat your friends on IQ Challenge!
Take the 10-Minute IQ Challenge today. Prove to your friends that you aren't stupid after all!
Related News:
- Greater Infection Risk with Staples in Hip Surgery (CME/CE)
- SGO: No Lung CA Risk Seen with Estrogen (CME/CE)
- Genetic variations influence statin efficacy for lowering colon cancer risk
- Heart transplant patients face greater risk of skin cancer
- Risk Factor Analysis In A Contemporary Cystectomy Cohort Using Standardized Reporting Methodology And Adverse Event Criteria
- Greater Infection Risk with Staples in Hip Surgery
- SIR: ABI Flags Those Not Otherwise at Risk for CVD
- Broken Hip Increases 10-Year Death Risk
- The Body’s Anticipation Of A Meal Can Be A Diabetes Risk Factor
- No Increased Risk of Death with ‘The Pill’
Details :
Submited at Monday, November 16th, 2009 at 1:01 pm on Psychiatry by robert
Comment RSS 2.0 - leave a comment - trackback
Leave Comment Here...